MSFAX
Price
$34.31
Change
-$0.48 (-1.38%)
Updated
Apr 3 closing price
Net Assets
2.72B
RWIBX
Price
$60.70
Change
-$2.20 (-3.50%)
Updated
Apr 3 closing price
Net Assets
123.19B
Ad is loading...

MSFAX vs RWIBX

Header iconMSFAX vs RWIBX Comparison
Open Charts MSFAX vs RWIBXBanner chart's image
Morgan Stanley Inst Global Franchise I
Price$34.31
Change-$0.48 (-1.38%)
VolumeN/A
Net Assets2.72B
American Funds Capital World Gr&Inc R2
Price$60.70
Change-$2.20 (-3.50%)
VolumeN/A
Net Assets123.19B
MSFAX vs RWIBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
MSFAX vs. RWIBX commentary
Apr 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MSFAX is a Buy and RWIBX is a Buy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RWIBX has more cash in the bank: 123B vs. MSFAX (2.72B). RWIBX pays higher dividends than MSFAX: RWIBX (0.92) vs MSFAX (0.66). MSFAX was incepted earlier than RWIBX: MSFAX (23 years) vs RWIBX (23 years). RWIBX (1.51) is less costly to investors than MSFAX (0.92). RWIBX is a more actively managed with annual turnover of: 27.00 vs. MSFAX (15.00). RWIBX has a lower initial minimum investment than MSFAX: RWIBX (250) vs MSFAX (1000000). RWIBX annual gain was more profitable for investors over the last year : -0.58 vs. MSFAX (-0.82). RWIBX return over 5 years is better than : 64.01 vs. MSFAX (48.16).
MSFAXRWIBXMSFAX / RWIBX
Total Expense Ratio0.921.5161%
Annual Report Gross Expense Ratio0.921.5161%
Fund Existence23 years23 years-
Gain YTD3.6650.679540%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets2.72B123B2%
Annual Yield % from dividends0.660.9272%
Returns for 1 year-0.82-0.58141%
Returns for 3 years4.709.5549%
Returns for 5 years48.1664.0175%
Returns for 10 years74.2137.24199%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
APVO1.990.61
+44.20%
Aptevo Therapeutics Inc
TR31.500.21
+0.67%
Tootsie Roll Industries Inc
BIO234.75-10.77
-4.39%
Bio-Rad Laboratories IncClass A
LCTX0.42-0.02
-4.55%
Lineage Cell Therapeutics
HLLY2.40-0.17
-6.61%
Holley